共 18 条
[1]
Duloxetine vs placebo in the treatment of stress urinary incontinence:a four-continent randomized clinical trial. Millard RJ,Moore K,Rencken R,et al. BJU International . 2004
[2]
Safety and tolerability of duloxetine in the treatment of major depressive disorder:analysis of pooled data from eight placebo-controlled clinical trials. Hudson JI,Wohlreich MM,Kajdasz DK,et al. Pharmacotherapy . 2005
[3]
A double-blind,multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arnold LM,Lu Y,Crofford LJ,et al. Arthritis and Rheumatism . 2004
[4]
The dual transporter inhibitor duloxetine:a review of its preclinical pharmacology,pharmacokinetic profile,and clinical results in depression. Bymaster FP,Lee TC,Knadler MP,et al. Current Pharmaceutical Design . 2005
[5]
Sexual functioning assessed in4double-blind placebo-and paroxetine-controlled trials of duloxetine for major depressive disorder. Delgado PL,Brannan SK,Mallinckrodt CH,et al. Journal of Clinical Psychiatry . 2005
[6]
Duloxetine increases serotonin and norepinephrine availability in healthy subjects:a double-blind,controlled study. Chalon SA,Granier LA,Vandenhende FR,et al. Neuropsychopharmacology . 2003
[7]
Pharmacokinetics and safety of duloxetine,a dual-serotonin and norepinephrine reuptake inhibitor. Sharma A,Goldberg MJ,Cerimele BJ. Journal of Clinical Pharmacology . 2000
[8]
Incidence and duration of antidepressant-induced nausea:Duloxetine compared with paroxetine and fluoxetine. Greist J,McNamara RK,Mallinckrodt CH. Clinical Therapeutics . 2004
[9]
Duloxetine pharmacokinetics incirrhotics compared with healthy subjects. Suri A,Reddy S,Gonzales C,et al. International Journal of Clinical Pharmacology Research . 2005
[10]
DRUGS[P]. DOI TAKAYUKI;YAMAMOTO MASAKI;FUKUI HIDEO.EP1145714A4,2004-12-15